A proposed mechanism of ADP-ribosylation catalyzed by the pertussis toxin S1 subunit.

Pertussis toxin is a complex protein composed of five different subunits, named S1 through S5 and arranged in an A-B structure. The B oligomer, composed of S2 through S5, is the receptor-binding moiety, and the A promoter, composed of S1, is the enzymatically active moiety. S1 catalyzes the ADP-ribosylation of a cysteine in the alpha subunit of heterotrimeric G proteins. In the absence of G proteins it also catalyzes the cleavage of NAD+ into ADP-ribose and nicotinamide. Molecular dissection has indicated that the C-terminal domain of S1 is involved in G-protein binding, while the N-terminal domain, homologous to other ADP-ribosylating toxins, contains the NAD(+)-binding site and the residues involved in catalysis. By site-directed mutagenesis and kinetic analyses Glu-129 and His-35 were identified as the catalytic residues. Glutamates analogous to Glu-129 are found in all studied ADP-ribosylating toxins, while His-35 is less well conserved. This suggests that Glu-129 acts on the common substrate NAD+, whereas His-35 plays its role on the acceptor substrates. We propose a mechanism in which Glu-129 exerts its action on the 2'-OH group of the NAD+ ribose, thereby facilitating the formation of an oxocarbonium-like intermediate and the weakening of the N-glycosidic bond. His-35 could increase the nucleophilicity of the cysteine in the G protein or the water molecule to attack the weakened N-glycosidic bond of NAD+ and yield the products of the reaction.

[1]  N. Oppenheimer Structural determination and stereospecificity of the choleragen-catalyzed reaction of NAD+ with guanidines. , 1978, The Journal of biological chemistry.

[2]  W. N. Burnette,et al.  Identification of a region in the S1 subunit of pertussis toxin that is required for enzymatic activity and that contributes to the formation of a neutralizing antigenic determinant. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[3]  L. Nencioni,et al.  Mutants of pertussis toxin suitable for vaccine development. , 1989, Science.

[4]  R. Collier,et al.  Enzymatically active peptide from the adenosine diphosphate-ribosylating toxin of Pseudomonas aeruginosa , 1977, Infection and immunity.

[5]  R. Collier,et al.  Active-site mutations of the diphtheria toxin catalytic domain: role of histidine-21 in nicotinamide adenine dinucleotide binding and ADP-ribosylation of elongation factor 2. , 1994, Biochemistry.

[6]  C. Locht,et al.  Roles of the disulfide bond and the carboxy-terminal region of the S1 subunit in the assembly and biosynthesis of pertussis toxin , 1990, Infection and immunity.

[7]  S. Cockle Identification of an active‐site residue in subunit S1 of pertussis toxin by photocrosslinking to NAD , 1989, FEBS letters.

[8]  Role of tryptophan 26 in the NAD glycohydrolase reaction of the S-1 subunit of pertussis toxin. , 1989, The Journal of biological chemistry.

[9]  J. Moss,et al.  Pertussis toxin-catalyzed ADP-ribosylation of transducin. Cysteine 347 is the ADP-ribose acceptor site. , 1985, The Journal of biological chemistry.

[10]  D. Burns,et al.  Adenine nucleotides promote dissociation of pertussis toxin subunits. , 1986, The Journal of biological chemistry.

[11]  T. Katada,et al.  Subunit structure of islet-activating protein, pertussis toxin, in conformity with the A-B model. , 1982, Biochemistry.

[12]  C. Locht,et al.  Photolabelling of mutant forms of the S1 subunit of pertussis toxin with NAD+. , 1990, The Biochemical journal.

[13]  A. Wardlaw,et al.  Pathogenesis and immunity in pertussis , 1988 .

[14]  Pertussis toxin S1 mutant with reduced enzyme activity and a conserved protective epitope. , 1988 .

[15]  N. Oppenheimer,et al.  Pyridine nucleotide chemistry: a new mechanism for the hydroxide-catalyzed hydrolysis of the nicotinamide-glycosyl bond , 1988 .

[16]  C. Dykes,et al.  Inactivation of the Escherichia coli heat-labile enterotoxin by in vitro mutagenesis of the A-subunit gene. , 1989, European journal of biochemistry.

[17]  R. Collier,et al.  Active-site mutations of diphtheria toxin: effects of replacing glutamic acid-148 with aspartic acid, glutamine, or serine. , 1990, Biochemistry.

[18]  R. Rappuoli,et al.  Subunit S1 of pertussis toxin: mapping of the regions essential for ADP-ribosyltransferase activity. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[19]  B. Ness,et al.  ADP-ribosylation of elongation factor 2 by diphtheria toxin. NMR spectra and proposed structures of ribosyl-diphthamide and its hydrolysis products. , 1980, The Journal of biological chemistry.

[20]  N. Oppenheimer,et al.  Photoaffinity labeling of diphtheria toxin fragment A with NAD: structure of the photoproduct at position 148. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[21]  R. Collier,et al.  Active site of Pseudomonas aeruginosa exotoxin A. Glutamic acid 553 is photolabeled by NAD and shows functional homology with glutamic acid 148 of diphtheria toxin. , 1987, The Journal of biological chemistry.

[22]  F. Schuber,et al.  The stereochemistry of calf spleen NAD‐glycohydrolase‐catalyzed NAD methanolysis , 1976, FEBS letters.

[23]  R. Read,et al.  The crystal structure of pertussis toxin. , 1994, Structure.

[24]  Role of cysteine 41 of the A subunit of pertussis toxin. , 1989, The Journal of biological chemistry.

[25]  C. Locht,et al.  Evidence for a catalytic role of glutamic acid 129 in the NAD-glycohydrolase activity of the pertussis toxin S1 subunit. , 1993, The Journal of biological chemistry.

[26]  C. Locht,et al.  Identification of amino acid residues essential for the enzymatic activities of pertussis toxin. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[27]  K. Tsurugi,et al.  The RNA N-glycosidase activity of ricin A-chain. The characteristics of the enzymatic activity of ricin A-chain with ribosomes and with rRNA. , 1988, The Journal of biological chemistry.

[28]  Katherine A. Kantardjieff,et al.  The crystal structure of diphtheria toxin , 1992, Nature.

[29]  Mutations affecting the activity of the Shiga-like toxin I A-chain. , 1992, Biochemistry.

[30]  J. Barbieri,et al.  Role of histidine 35 of the S1 subunit of pertussis toxin in the ADP-ribosylation of transducin. , 1994, The Journal of biological chemistry.

[31]  T. Sixma,et al.  Crystal structure of a cholera toxin-related heat-labile enterotoxin from E. coli , 1991, Nature.

[32]  J. Hindley,et al.  Cloning, sequencing, and expression of a gene encoding a 100-kilodalton mosquitocidal toxin from Bacillus sphaericus SSII-1 , 1991, Journal of bacteriology.

[33]  A. Monzingo,et al.  X-ray analysis of substrate analogs in the ricin A-chain active site. , 1992, Journal of molecular biology.

[34]  E. Hewlett,et al.  Activation by thiol of the latent NAD glycohydrolase and ADP-ribosyltransferase activities of Bordetella pertussis toxin (islet-activating protein). , 1983, The Journal of biological chemistry.

[35]  J. Munoz,et al.  BIOLOGICAL ACTIVITIES OF PERTUSSIGEN (PERTUSSIS TOXIN) , 1985 .

[36]  V. G. Johnson,et al.  Histidine 21 does not play a major role in diphtheria toxin catalysis. , 1994, The Journal of biological chemistry.

[37]  C. Locht,et al.  The role of cysteine 41 in the enzymatic activities of the pertussis toxin S1 subunit as investigated by site-directed mutagenesis. , 1990, The Journal of biological chemistry.

[38]  R. Rappuoli,et al.  Cloning and sequencing of the pertussis toxin genes: operon structure and gene duplication. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[39]  D. Mckay,et al.  Structure of exotoxin A of Pseudomonas aeruginosa at 3.0-Angstrom resolution. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[40]  L. Birnbaumer,et al.  Peptide inhibitors of ADP-ribosylation by pertussis toxin are substrates with affinities comparable to those of the trimeric GTP-binding proteins. , 1992, Molecular pharmacology.

[41]  T. Katada,et al.  Two guanine nucleotide-binding proteins in rat brain serving as the specific substrate of islet-activating protein, pertussis toxin. Interaction of the alpha-subunits with beta gamma-subunits in development of their biological activities. , 1986, The Journal of biological chemistry.

[42]  C. Locht,et al.  Pertussis toxin gene: nucleotide sequence and genetic organization. , 1986, Science.

[43]  N. Oppenheimer,et al.  Diphtheria toxin. Site and configuration of ADP-ribosylation of diphthamide in elongation factor 2. , 1981, The Journal of biological chemistry.

[44]  M. Noda,et al.  Glutamic acid‐112 of the A subunit of heat‐labile enterotoxin from enterotoxigenic Escherichia coli is important for ADP‐ribosyltransferase activity , 1991, FEBS letters.

[45]  R. Collier,et al.  NAD binding site of diphtheria toxin: identification of a residue within the nicotinamide subsite by photochemical modification with NAD. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[46]  C. Locht,et al.  Site-specific alterations in the B oligomer that affect receptor- binding activities and mitogenicity of pertussis toxin , 1993, The Journal of experimental medicine.

[47]  J. Mekalanos,et al.  Enzymic activity of cholera toxin. I. New method of assay and the mechanism of ADP-ribosyl transfer. , 1979, The Journal of biological chemistry.

[48]  R. Collier,et al.  Pseudomonas aeruginosa exotoxin A: alterations of biological and biochemical properties resulting from mutation of glutamic acid 553 to aspartic acid. , 1990, Biochemistry.

[49]  John,et al.  Interaction of fragment A from diphtheria toxin with nicotinamide adenine dinucleotide. , 1974, The Journal of biological chemistry.